glp-1 tri Support, Essential Sources – Professional Supplement Center GLP-1-based therapies for type 2

This finding is consistent with the growing body of evidence linking gut microbiota transformations of dietary polyphenols to systemic metabolic effects [17]

CONTRAINDICATIONS GLP-1 or incretin-based therapy may not be appropriate for individuals with: Personal or family history of medullary thyroid carcinoma History of MEN2 syndrome Active pancreatitis or recurrent pancreatitis history Severe gastroparesis or significant GI motility disorders Certain gallbladder disease without evaluation Pregnancy or breastfeeding Known hypersensitivity to GLP-1 peptide therapy components Caution is used in patients with : Advanced kidney disease Eating disorders Rapid unexplained weight loss Concurrent medications affecting gastric emptying Uncontrolled psychiatric illness affecting nutrition Potential Benefits of GLP-1 Peptide Therapy: When used within a structured medical program such as the R.E.A.L

Contact your healthcare provider to avoid dehydration and other complications

Similarly, Volpe et al

We start at a low dose and increase gradually based on how you respond